Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
This study is currently recruiting participants.
Verified April 2011 by University of Vermont
Sponsor:
University of Vermont
Information provided by:
University of Vermont
ClinicalTrials.gov Identifier:
NCT01148407
First received: June 21, 2010
Last updated: April 21, 2011
Last verified: April 2011
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | June 21, 2010 | ||||
| Last Updated Date | April 21, 2011 | ||||
| Start Date ICMJE | June 2010 | ||||
| Estimated Primary Completion Date | August 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT01148407 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer | ||||
| Official Title ICMJE | Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer | ||||
| Brief Summary | Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Not Provided | ||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples Without DNA Description: plasma, serum and platelet activated blood samples |
||||
| Sampling Method | Probability Sample | ||||
| Study Population | Patients with a malignancy diagnosis. |
||||
| Condition ICMJE | Cancer | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 30 | ||||
| Estimated Completion Date | August 2013 | ||||
| Estimated Primary Completion Date | August 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01148407 | ||||
| Other Study ID Numbers ICMJE | VCC 0806 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Chris E. Holmes, MD, PhD, University of Vermont | ||||
| Study Sponsor ICMJE | University of Vermont | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | University of Vermont | ||||
| Verification Date | April 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||